Epratuzumab (LymphoCide)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 18:26, 20 May 2018 by Warner-admin (talk | contribs) (Text replacement - "http://onlinelibrary.wiley.com" to "https://onlinelibrary.wiley.com")
Jump to navigation Jump to search

Mechanism of action

Anti-CD22 antibody

Preliminary data

Acute lymphocytic leukemia

  1. Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M, Appelbaum FR. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 May;165(4):504-9. Epub 2014 Mar 3. PubMed link to original article
Retrieved from "https://hemonc.org/w/index.php?title=Epratuzumab_(LymphoCide)&oldid=26870"